Meihua International Medical Technologies Co., Ltd. (MHUAF) — Available-Data Snapshot

We don't publish a discounted-cash-flow fair value for Meihua International Medical Technologies Co., Ltd. (MHUAF) because the free data sources we rely on don't expose the multi-year financials a DCF needs — common for small or thinly-covered listings. Rather than invent numbers, this page shows an honest snapshot of what the public data does support: the current price and size, any relative valuation multiples that exist, a book-value view, and a price-based read. Treat it as a descriptive starting point, not a valuation and not investment advice.

On the numbers we do have, MHUAF trades at a recent price of $7.13, a market capitalisation of about $6,100,392, sitting 11% of the way up its 52-week range ($2.05–$50.00), on the OTC Markets OTCID.

The standard alternative to a DCF is relative valuation — comparing MHUAF's trading multiples against a sector benchmark. Here that gives P/E of 0.4× (cheaper than the peer median of 38.9×); P/B of 0.0× (cheaper than the peer median of 8.4×); P/S of 0.1× (cheaper than the peer median of 6.8×); EV/EBITDA of -0.1× (cheaper than the peer median of 17.1×). A cheaper multiple than peers can flag a discount or a market that expects weaker growth; it is a comparison, not a recommendation.

The asset, or book-value, lens is the classic tool for asset-heavy businesses and financials. MHUAF shows a price-to-book (P/B) of 0.03 and book value of $271.61 per share. Price-to-book compares the market price to the accounting net-asset value per share; below 1.0 can mean a discount to net assets or that the market is pricing in trouble — descriptive either way, never a buy signal on its own.

Finally, a price-based read — explicitly not a valuation. MHUAF is in a down-trend (price below both its 50- and 200-day averages), trading -85.7% from its 52-week high. Over the past year the stock is -81.2%. Moving-average trend and 52-week position describe where the stock has traded; they say nothing about what it is worth.

What's missing and why: we can't build a DCF for MHUAF because the data source doesn't reliably provide dividend. This is a very small-cap listing — reported figures can be sparse, stale or volatile, and a few large trades can move the price sharply. It trades thinly (low average volume), so quoted prices and any derived metrics should be treated with extra caution. We would rather say so plainly than manufacture a precise-looking number from nothing. As coverage improves, or for larger and more widely-followed listings, a full intrinsic-value model becomes possible.